Orbital Center of Academic Medical Center, Department of Ophthalmology, University of Amsterdam, Amsterdam, The Netherlands.
Br J Ophthalmol. 2011 Jul;95(7):996-1000. doi: 10.1136/bjo.2010.189050. Epub 2011 Jan 17.
To evaluate the outcome of surgery and radiotherapy in the treatment of sphenoorbital meningioma (SOM).
A retrospective study of 66 consecutive cases treated with surgery for SOM with a minimum follow-up of 4 years. Clinical and radiological information were compared before and after the following surgical approaches: frontotemporal craniotomy, frontotemporal craniotomy combined with orbitozygomatic resection and extended lateral orbitotomy alone.
The median age at presentation was 46 years (range, 26-68 years) and the median follow-up after surgery was 102 months (range, 48-288 months). In total, 48 (73%) patients showed preoperative visual deterioration, with visual field defects. All patients had proptosis at presentation (mean ± SD=6.4 ± 3.0 mm). Surgery for patients with SOM arrested visual deterioration in 61% and improved vision in 30% of cases. Furthermore, a substantial reduction of proptosis was achieved in 85% of patients. The proptosis in this group was reduced by 2.6 ± 2.6 mm. There was no correlation between surgical approach and proptosis reduction (p = 0.125). The recurrence rate was 17%. Only 1 out of 15 patients who underwent radiotherapy showed signs of recurrence.
The surgical aims in the treatment of SOM should be the restoration of visual acuity and reduction of proptosis, rather than complete tumour removal. The surgical approach can be tailored to individual cases. The authors recommend radiotherapy in cases of subtotally removed SOM.
评估手术和放疗治疗蝶眶脑膜瘤(SOM)的疗效。
对 66 例 SOM 患者进行了回顾性研究,这些患者均接受了手术治疗,随访时间至少为 4 年。比较了以下手术入路前后的临床和影像学资料:额颞开颅术、额颞开颅术联合眶颧切除术和单纯外侧眶切开术。
患者的中位年龄为 46 岁(范围:26-68 岁),手术后的中位随访时间为 102 个月(范围:48-288 个月)。术前共有 48 例(73%)患者存在视力恶化,表现为视野缺损。所有患者均有眼球突出(平均值±标准差=6.4±3.0mm)。SOM 患者的手术治疗使 61%的患者视力恶化停止,30%的患者视力改善。此外,85%的患者眼球突出得到了显著缓解。该组患者的眼球突出减少了 2.6±2.6mm。手术入路与眼球突出缓解之间无相关性(p=0.125)。复发率为 17%。仅 15 例接受放疗的患者中有 1 例出现复发迹象。
SOM 治疗的手术目标应是恢复视力和减轻眼球突出,而不是完全切除肿瘤。手术入路可以根据个体情况进行调整。对于未完全切除的 SOM,作者建议行放疗。